March 14-16, 2017
Immune Checkpoint Inhibitors 2017
Sheraton Boston Hotel • Boston, MA
DiscoverX booth in exhibit area
Presentation—Wednesday, March 15, 4−4:30 p.m.
Harnessing the Complexity of the Human Tumor Microenvironment to Guide Decisions in Discovery and Combinations
- Novel, Improved Cell-based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
- Immune Checkpoint Inhibitor Profiling and Biomarker Identification Using Human Primary Cell BioMAP® Oncology Systems